TickerFactsScreenerDevelopers

TuHURA Biosciences, Inc./NV (HURA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $24.4K2011: $15.0K2012: $17.8K2013: $4.14M2014: $4.76M2015: $1.75M2016: $6.16M2017: $6.59M2018: $5.97M2019: $3.72M2020: $2.39M2021: $10.54M2022: $11.78M2023: $3.67M2024: $12.66M2025: $3.62M$3.62M
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$3.62M-71.4%
2024$12.66M+245.3%
2023$3.67M-68.9%
2022$11.78M+11.8%
2021$10.54M+340.5%
2020$2.39M-35.7%
2019$3.72M-37.7%
2018$5.97M-9.3%
2017$6.59M+7.0%
2016$6.16M+251.0%
2015$1.75M-63.1%
2014$4.76M+15.1%
2013$4.14M+23164.0%
2012$17.8K+18.4%
2011$15.0K-38.4%
2010$24.4K—